Loss of COP9 signalosome gene-containing 2q region is associated with lenalidomide and pomalidomide resistance in myeloma patients
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Conference item |
Language: | English |
Published: |
American Society of Hematology
2021
|